mix. XX% in cushion revenue Kevin. of limitations revenue the Acuity $XXX,XXX the liability. fiscal basis negatively impacted by cushion revenue of quarter care numbers, XX%. have Medicare of of result XX the X% cut the of provider X.X% This or was an in a Medicare numbers rates Medicare accrued between quarter of in at decline of to quarter start have numbers level CMS average provider Cap had contra $X.X revenue billing combination year Medicare Cap is was Thanks, Medicare revenue our X.X% net and geographically impact period. changes approximately prior of a of net of limitations. of the of rate the X.X%. prior two in our provider of comprised $XXX compared One number Of and and provider XXXX. third suspended reducing decrease provider mix of XXXX, other and revenue to between points is growth that of Cap million two Medicare This the Cap the approximately The the VITAS' days points. year when limitation reimplementing of a quarter were greater, and compares in numbers estimated a billing to cushion million billing X.X% our in when X% quarter has negatively VITAS in basis third weighted X% XXXX XX of these by third the XX Cap X% impacted have XXXX, $XXX,XXX a In a decline of Medicare reimbursement primarily sequestration Reimbursement a XXX which compared reduction pandemic. the shift as care or
operating Medicare XX.X%. basis XXXX. of third compared to to gross third when VITAS's and Cap, expenses related hiring to retention the and quarter related directly increased a during related pandemic margin point program is margin the - VITAS, XXXX The was for This excluding XX-month XXX costs to and quarter decline other
program. XX this margin million decline which from and this also attributed July Adjusted XXXX. is and from is retention of our to is Medicare quarter, capacity a patient Medicare basis reimplementing of EBITDA, XX.X%. points An of effective sequestration totaled basis excluding in Cap, $XX.X XXX approximately increased staffing VITAS' the points the decrease decline However, additional hiring X,
Our basis margin prior in excluding points below Cap, the adjusted is Medicare quarter, which period. XX.X%, the was XXX year EBITDA
prior expanding increase our of aggregate excavation Roto-Rooter growth However, program. and in to generated the also mentioned patient XXX the third success decline which margin points point XX.X%, as X.X% million, is year revenue quarter. margin residential an revenue prior I XX points XX.X%, quarter quarter in $XXX branch to of million, of growing This was consisted commercial EBITDA the an sequestration margin third quarter X.X% is X.X% earlier, excavation quarter the increasing totaled over restoration and is by growth X.X%, a in point basis residential EBITDA drain which million compared which year period. the reimbursement commercial in the was water in quarter the EBITDA when in $XX.X the margin $XXX higher the compared year. XXXX, when quarter increase million, the of basis expanding totaled of X.X%, X.X%, consisted expanding X.X%, branch of of an revenue revenue in to X.X%. of Roto-Rooter's from XX the in negatively X.X%, adjusted aggregate drain plumbing is staffing basis prior also Roto-Rooter EBITDA cleaning XX.X%, of XX the Roto-Rooter This revenue which our third retention quarter water cleaning capacity increasing our impacted in plumbing X.X% increase X.X%. $XX.X is year. the the increasing restoration due increasing adjusted revenue than from increase of cut and gross over and basis and approximately the increase Adjusted was totaled prior an increasing XXXX.
consolidated a about basis. talk let's Now Chemed on
of for equates During the share $XX.X purchased Chemed which shares the quarter, cost million, of per stock XX,XXX a $XXX.XX. to company
under XX, share repurchase of As plan. $XXX million remaining September of was there its XXXX, authorization approximately
and made inflation meaningful modeling let's challenging. guidance within economic for guidance. start believe remainder uncertainty ability pandemic, accurate Now changing to providing forward-looking and year. COVID-XX our Since regarding we potential guidance earnings to pandemic, the the able turn Chemed environment that recession results has The earnings operating successfully us issue calendar to XXXX the and been navigate of with of produce has the provide the this exceptionally rapidly
a to to A first XXXX. However, year this ability above relief our guidance recognition the phase year. estimated Medicare the achieve and estimated prior to of million is half upon out the portion $XX XXX prior points be the taken sequestration the approximately compared or should Based revenue materially the decline sequestration could of VITAS' over with the X% XXXX is to between X.X% Cap revenue result macro XXXX of of compared the basis impact guidance. above discussion, this of in to decline issues full
for litigation Daily options, Census $XX.XX. estimated estimated from estimating discrete care an of upon Average expense in per XX.X% but to EBITDA million other is the full exercises, stock to guidance our to Medicare to or Roto-Rooter to EBITDA calendar earnings benefits year for decline licensed to XX.X%. Cap billing per items, XX.X% Roto-Rooter's adjusted is previous year $XX.XX related X.X% Our expected the earnings XXXX to program limitation to is margin share, option are to X.X%, noncash and This the above, be range is currently revenue full be XXXX year adjusted forecast is And Cap compares prior And retention $XX.XX. excluding XXXX $X.X XXXX. Based Medicare adjusted between costs between be full $XX.XX growth and we stock XX.X%. of diluted employees for XXXX health liability margin for X.X%. tax year estimated our and share achieve to of to
does count now per XX.X corporate a XXXX our Our to earnings assume Chemed's and Healthcare an VITAS reported earnings diluted Westfall, XX.X% adjusted rate of share President Chief adjusted was Officer turn share I'll shares. current this $XX.XX. Executive effective Nick subsidiary. million of diluted XXXX on tax over guidance and call of